2-NBDG: Fluorescent Glucose Analog for Quantitative Glucose Uptake Assay

Executive Summary: 2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) is a fluorescent glucose analog that directly quantifies glucose uptake in live cells and tissues with single-cell resolution using flow cytometry, microscopy, or microplate assays (APExBIO). The compound enters cells through glucose transporter proteins and is phosphorylated by hexokinase, leading to intracellular fluorescence retention. 2-NBDG is soluble in water (≥17.1 mg/mL) and ethanol (≥2.93 mg/mL) under controlled laboratory conditions. It is widely applied in research on metabolic disorders such as diabetes, epilepsy, and cancer, and enables rapid, reproducible assessment of glucose uptake kinetics in diverse biological models (Hong et al., 2025).

Biological Rationale

Glucose uptake is a fundamental cellular process mediated by glucose transporter (GLUT) proteins. Quantifying this uptake is essential for understanding pathophysiological states such as diabetes mellitus, cancer, and neurological disorders [Hong et al., 2025]. Traditional assays lack the resolution and specificity needed for real-time or single-cell analysis. Fluorescent glucose analogs like 2-NBDG enable direct, quantitative measurement of glucose transport and metabolism across cell types and experimental models (see here for a review of sensitivity advantages).

Mechanism of Action of 2-NBDG

2-NBDG mimics the structure of 2-deoxyglucose, with a nitrobenzoxadiazole (NBD) fluorophore covalently attached to the 2-position. The compound enters cells via facilitative GLUT family transporters, predominantly GLUT1 and GLUT3. Once inside, 2-NBDG is phosphorylated by hexokinase to 2-NBDG-6-phosphate, which is membrane-impermeant and accumulates intracellularly (APExBIO B6035 documentation). The retained NBD fluorescence can be detected at excitation/emission maxima of ~465/540 nm, enabling sensitive quantification of glucose uptake in live cells and tissues. Uptake is rapid (within 1–5 minutes) and typically plateaus within 20–30 minutes in MCF-7 breast cancer cells under standard conditions (10 μM, 37°C) (related article).

Evidence & Benchmarks

• 2-NBDG enables direct quantification of glucose uptake in live HepG2, L6, MCF-7, and astrocyte cell lines via flow cytometry and fluorescence microscopy (DOI).
• Solubility benchmarks: ≥17.1 mg/mL in water (with ultrasonic treatment); ≥2.93 mg/mL in ethanol (with mild warming, 37°C, and ultrasonic agitation) (APExBIO).
• 2-NBDG is retained in cells following phosphorylation by hexokinase, ensuring low background and high specificity for glucose uptake (see mechanistic review).
• In diabetes models, 2-NBDG uptake is used to quantify impaired glucose transport and assess intervention efficacy, as demonstrated in quercetin-treated GDM mouse hepatocytes (DOI).
• 2-NBDG supports in vivo imaging of epileptic foci in rat brain and glucose metabolism mapping in tumor xenografts (see translational perspective).

Applications, Limits & Misconceptions

2-NBDG is used in:

• Diabetes research: assessment of hepatic and peripheral glucose uptake, including insulin-responsiveness and intervention studies (Hong et al., 2025).
• Cancer metabolism: quantification of increased glycolytic flux in tumor cells and response to metabolic inhibitors (site article).
• Neurological models: localization of epileptic foci in animal brains using in vivo 2-NBDG imaging.
• Routine metabolic assays: rapid, reproducible glucose uptake measurement in cell lines (e.g., HepG2, MCF-7, L6).

Common Pitfalls or Misconceptions

• 2-NBDG is not metabolized beyond phosphorylation; it does not enter glycolysis, so cannot be used to trace downstream metabolic flux.
• It is insoluble in DMSO; attempts to dissolve in DMSO lead to precipitation and assay interference (APExBIO).
• Long-term storage of stock solutions (>2–3 months) leads to decreased fluorescence and unreliable performance; always prepare fresh stocks for critical assays.
• Not all cell types express sufficient GLUT1/GLUT3 for robust signal; verify transporter expression for new models.
• Background autofluorescence at NBD wavelengths may require compensation controls in some tissue types.

This article extends prior reviews (e.g., here) by providing updated solubility and storage guidelines, and clarifies the tracer's boundaries versus alternative metabolic probes.

Workflow Integration & Parameters

Preparation: Dissolve 2-NBDG in water (≥17.1 mg/mL) or ethanol (≥2.93 mg/mL) with ultrasonic agitation; warming to 37°C improves yield. Do not use DMSO as a solvent. Store stock solutions at ≤–20°C for up to several months; avoid repeated freeze-thaw cycles. For cell-based assays, typical working concentration is 10 μM, with 10 minutes incubation at 37°C. Uptake is rapid (1–5 minutes), plateauing at 20–30 minutes in MCF-7 cells. Analyze by flow cytometry (excitation 465 nm, emission 540 nm), fluorescence microscopy, or plate reader.

Controls: Always include negative (no 2-NBDG) and transporter-inhibited controls. For animal studies, inject 2-NBDG intravenously and image using appropriate in vivo fluorescence systems.

For a practical laboratory protocol and troubleshooting, see the guide on Enhancing Glucose Uptake Assays, which complements this article by focusing on hands-on workflow integration.

Conclusion & Outlook

2-NBDG (APExBIO SKU B6035) is a gold-standard fluorescent glucose analog for quantitative measurement of cellular glucose uptake. Its specificity, rapid uptake, and compatibility with flow cytometry and microscopy make it indispensable for metabolic research across disease models. Limitations include lack of downstream metabolic tracing and DMSO insolubility, but these are outweighed by technical robustness and reproducibility. Ongoing developments aim to refine in vivo imaging and multiplexed metabolic analyses. Visit the official APExBIO 2-NBDG page for detailed specifications and ordering information.